Journal ArticleDOI
2016 IMS Recommendations on women’s midlife health and menopause hormone therapy
Reads0
Chats0
TLDR
In preparing these international recommendations, experts have taken into account geographical variations in medical care, prevalence of diseases, and country-specific attitudes of the public, medical community and health authorities towards menopause management.Abstract:
The International Menopause Society (IMS) has produced these new 2016 recommendations on women’s midlife health and menopause hormone therapy (MHT) to help guide health-care professionals in optimizing their management of women in the menopause transition and beyond. The term MHT has been used to cover therapies including estrogens, progestogens and combined regimens. For the first time, the 2016 IMS recommendations now include grades of recommendations, levels of evidence and 'good practice points', in addition to section-specific references. Where possible, the recommendations are based on and linked to the evidence that supports them, unless good-quality evidence is absent. Particular attention has been paid to published evidence from 2013 onwards, the last time the IMS recommendations were updated. Databases have been extensively searched for relevant publications using key terms specific to each specialist area within menopause physiology and medicine. Information has also been drawn from int...read more
Citations
More filters
Journal ArticleDOI
Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting
Claus Højbjerg Gravholt,Niels Holmark Andersen,Gerard S. Conway,Olaf M. Dekkers,Mitchell E. Geffner,Karen O Klein,Angela E. Lin,Nelly Mauras,Charmian A. Quigley,Karen Rubin,David E. Sandberg,Theo C. J. Sas,Michael Silberbach,Viveca Söderström-Anttila,Kirstine Stochholm,Janielle A van Alfen-van derVelden,Joachim Woelfle,Philippe Backeljauw +17 more
TL;DR: An international effort that started with exploratory meetings in 2014 in both Europe and the USA, and culminated with a Consensus Meeting held in Cincinnati, Ohio, USA in July 2016, the present guidelines related to the efficacy and most optimal treatment of short stature, infertility, hypertension, and hormonal replacement therapy.
Journal ArticleDOI
Emerging trends in the novel drug delivery approaches for the treatment of lung cancer
Parvarish Sharma,Meenu Mehta,Daljeet Singh Dhanjal,Simran Kaur,Gaurav Gupta,Harjeet Singh,Lakshmi Thangavelu,Shanmugam Rajeshkumar,Murtaza M. Tambuwala,Hamid A. Bakshi,Dinesh Kumar Chellappan,Kamal Dua,Saurabh Satija +12 more
TL;DR: In this review, various modes of nano drug delivery options like liposomes, dendrimers, quantum dots, carbon nanotubes and metallic nanoparticles have been discussed.
Journal ArticleDOI
Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association
Samar R. El Khoudary,Brooke Aggarwal,Theresa M. Beckie,Howard N. Hodis,Amber E. Johnson,Robert Langer,Marian C. Limacher,JoAnn E. Manson,Marcia L. Stefanick,Matthew A. Allison +9 more
TL;DR: The reported findings underline the significance of the MT as a time of accelerating CVD risk, thereby emphasizing the importance of monitoring women's health during midlife, a critical window for implementing early intervention strategies to reduce CVDrisk.
Journal ArticleDOI
Hormone-replacement therapy: current thinking
TL;DR: In younger healthy women (aged 50–60 years), the risk–benefit balance is positive for using HRT, with risks considered rare, and some consideration might be given to HRT as a prevention strategy as treatment can reduce CHD and all-cause mortality.
Journal ArticleDOI
Revised Global Consensus Statement on Menopausal Hormone Therapy
T. J. de Villiers,Janet E. Hall,JoAnn V. Pinkerton,S. Cerdas Pérez,Margaret Rees,C. Yang,D. D. Pierroz +6 more
TL;DR: The following Consensus Statement is endorsed by The International Menopause Society, The North American Menopausal Association, The Endocrine Society, and The European Menopausal Society.
References
More filters
Journal ArticleDOI
Diagnostic and Statistical Manual of Mental Disorders
Vijay A. Mittal,Elaine F. Walker +1 more
TL;DR: An issue concerning the criteria for tic disorders is highlighted, and how this might affect classification of dyskinesias in psychotic spectrum disorders.
Journal ArticleDOI
Global cancer statistics, 2012
Lindsey A. Torre,Freddie Bray,Rebecca L. Siegel,Jacques Ferlay,Joannie Lortet-Tieulent,Ahmedin Jemal +5 more
TL;DR: A substantial portion of cancer cases and deaths could be prevented by broadly applying effective prevention measures, such as tobacco control, vaccination, and the use of early detection tests.
Journal ArticleDOI
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial
Jacques E. Rossouw,Garnet L. Anderson,Ross L. Prentice,Andrea Z. LaCroix,Charles Kooperberg,Marcia L. Stefanick,Rebecca D. Jackson,Shirley A.A. Beresford,Barbara V. Howard,Karen C. Johnson,Jane Morley Kotchen,Judith K. Ockene +11 more
TL;DR: Overall health risks exceeded benefits from use of combined estrogen plus progestin for an average 5.2-year follow-up among healthy postmenopausal US women, and the results indicate that this regimen should not be initiated or continued for primary prevention of CHD.
Journal Article
[Affective disorders in the fourth edition of the classification of mental disorders prepared by the American Psychiatric Association -- diagnostic and statistical manual of mental disorders].
Journal ArticleDOI
Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
Stephen B. Hulley,Deborah Grady,Trudy L. Bush,Curt D Furberg,David M. Herrington,Betty Riggs,Eric Vittinghoff +6 more
TL;DR: Treatment with oral conjugated equine estrogen plus medroxyprogesterone acetate did not reduce the overall rate of CHD events in postmenopausal women with established coronary disease and the treatment did increase the rate of thromboembolic events and gallbladder disease.
Related Papers (5)
The 2017 hormone therapy position statement of The North American Menopause Society.
JoAnn V. Pinkerton,Fernando Sánchez Aguirre,Jennifer Blake,Felicia Cosman,Howard N. Hodis,Susan Hoffstetter,Andrew M. Kaunitz,Sheryl A. Kingsberg,Pauline M. Maki,JoAnn E. Manson,Polly Marchbanks,Michael R. McClung,Lila E. Nachtigall,Lawrence M. Nelson,Diane Todd Pace,Robert L. Reid,Phillip M. Sarrel,Jan L. Shifren,Cynthia A. Stuenkel,Wulf H. Utian +19 more
Menopausal Hormone Therapy and Health Outcomes During the Intervention and Extended Poststopping Phases of the Women’s Health Initiative Randomized Trials
JoAnn E. Manson,Rowan T. Chlebowski,Marcia L. Stefanick,Aaron K. Aragaki,Jacques E. Rossouw,Ross L. Prentice,Garnet L. Anderson,Barbara V. Howard,Cynthia A. Thomson,Andrea Z. LaCroix,Jean Wactawski-Wende,Rebecca D. Jackson,Marian C. Limacher,Karen L. Margolis,Sylvia Wassertheil-Smoller,Shirley A.A. Beresford,Jane A. Cauley,Charles B. Eaton,Margery Gass,Judith Hsia,Karen C. Johnson,Charles Kooperberg,Lewis H. Kuller,Cora E. Lewis,Simin Liu,Lisa W. Martin,Judith K. Ockene,Mary Jo O'Sullivan,Lynda H. Powell,Michael S. Simon,Linda Van Horn,Mara Z. Vitolins,Robert B. Wallace +32 more
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial
Garnet L. Anderson,Marian C. Limacher,Annlouise R. Assaf,Tamsen Bassford,Shirley A.A. Beresford,Henry R. Black,Denise E. Bonds,Robert L. Brunner,Robert G. Brzyski,Bette J. Caan,Rowan T. Chlebowski,J. David Curb,Margery Gass,Jennifer Hays,Gerardo Heiss,Susan L. Hendrix,Barbara V. Howard,Judith Hsia,F. Allan Hubbell,Rebecca D. Jackson,Karen C. Johnson,Howard L. Judd,Jane Morley Kotchen,Lewis H. Kuller,Andrea Z. LaCroix,Dorothy S. Lane,Robert Langer,Norman L. Lasser,Cora E. Lewis,JoAnn E. Manson,Karen L. Margolis,Judith K. Ockene,Mary Jo O'Sullivan,Lawrence S. Phillips,Ross L. Prentice,Cheryl Ritenbaugh,John A Robbins,Jacques E. Rossouw,Gloria E. Sarto,Marcia L. Stefanick,Linda Van Horn,Jean Wactawski-Wende,Robert B. Wallace,Sylvia Wassertheil-Smoller +43 more